Literature DB >> 17920038

Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells.

Hisamitsu Ide1, Takashi Nakagawa, Yuichi Terado, Yutaka Kamiyama, Satoru Muto, Shigeo Horie.   

Abstract

Protein tyrosine kinase plays a central role in the proliferation and differentiation of various types of cells. One of these protein kinases, Tyk2, a member of the Jak family kinases, is known to play important roles in receptor signal transduction by interferons, interleukins, growth factors, and other hormones. In the present study, we investigated Tyk2 expression and its role in the growth and invasiveness of human prostate cancer cells. We used a small interfering RNA targeting Tyk2 and an inhibitor of Tyk2, tyrphostin A1, to suppress the expression and signaling of Tyk2 in prostate cancer cells. We detected mRNAs for Jak family kinases in prostate cancer cell lines by RT-PCR and Tyk2 protein in human prostate cancer specimens by immunohistochemistry. Inhibition of Tyk2 signaling resulted in attenuation of the urokinase-type plasminogen activator-enhanced invasiveness of prostate cancer cells in vitro without affecting the cellular growth rate. These results suggest that Tyk2 signaling in prostate cancer cells facilitate invasion of these cells, and interference with this signaling may be a potential therapeutic pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920038     DOI: 10.1016/j.bbrc.2007.08.160

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Non-receptor tyrosine kinase 2 reaches its lowest expression levels in human breast cancer during regional nodal metastasis.

Authors:  Qing-Xiang Amy Sang; Yan-Gao Man; You Me Sung; Zahraa I Khamis; Lihua Zhang; Mi-Hye Lee; Stephen W Byers; Ziad J Sahab
Journal:  Clin Exp Metastasis       Date:  2011-11-25       Impact factor: 5.150

2.  The expression and the tumor suppressor role of CLDN6 in colon cancer.

Authors:  Huinan Qu; Min Wang; Miaomiao Wang; Yuanyuan Liu; Chengshi Quan
Journal:  Mol Cell Biochem       Date:  2022-06-14       Impact factor: 3.396

3.  Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma.

Authors:  Mohd Altaf Najar; Mohammad Arefian; David Sidransky; Harsha Gowda; T S Keshava Prasad; Prashant Kumar Modi; Aditi Chatterjee
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

4.  Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models.

Authors:  Eloisi Caldas-Lopes; Leandro Cerchietti; James H Ahn; Cristina C Clement; Ana I Robles; Anna Rodina; Kamalika Moulick; Tony Taldone; Alexander Gozman; Yunke Guo; Nian Wu; Elisa de Stanchina; Julie White; Steven S Gross; Yuliang Ma; Lyuba Varticovski; Ari Melnick; Gabriela Chiosis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-05       Impact factor: 11.205

5.  The role of Tyk2 in regulation of breast cancer growth.

Authors:  Qifang Zhang; Jamie L Sturgill; Maciej Kmieciak; Karol Szczepanek; Marta Derecka; Catherine Koebel; Laura J Graham; Yun Dai; Shuang Chen; Steven Grant; Joanna Cichy; Kazuya Shimoda; Ana Gamero; Masoud Manjili; Harry Bear; Daniel Conrad; Andrew C Larner
Journal:  J Interferon Cytokine Res       Date:  2011-08-24       Impact factor: 2.607

Review 6.  PPAR gamma, bioactive lipids, and cancer progression.

Authors:  Gregory T Robbins; Daotai Nie
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

7.  Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo.

Authors:  Xuechao Jia; Chuntian Huang; Yamei Hu; Qiong Wu; Fangfang Liu; Wenna Nie; Hanyong Chen; Xiang Li; Zigang Dong; Kangdong Liu
Journal:  J Exp Clin Cancer Res       Date:  2021-03-17

8.  Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.

Authors:  Il-Rae Cho; Myungju Oh; Sang Seok Koh; Waraporn Malilas; Ratakorn Srisuttee; Byung Hak Jhun; Sandra Pellegrini; Serge Y Fuchs; Young-Hwa Chung
Journal:  Int J Mol Med       Date:  2012-01-03       Impact factor: 4.101

9.  Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements.

Authors:  Joana Santos; Diana Mesquita; João D Barros-Silva; Carmen Jerónimo; Rui Henrique; António Morais; Paula Paulo; Manuel R Teixeira
Journal:  Oncoscience       Date:  2015-03-17

10.  Establishing the role of tyrosine kinase 2 in cancer.

Authors:  Caroline Ubel; Stephanie Mousset; Denis Trufa; Horia Sirbu; Susetta Finotto
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.